Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mansell, Peter"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stanulewicz, Natalia, Mansell, Peter, Cooke, Debbie, Hopkins, David, Speight, Jane, Blake, Holly
Objective: The Problem Areas In Diabetes (PAID) questionnaire is widely used to assess emotional distress related to living with diabetes, although it is lengthy for routine clinical use. Our aim was to determine whether the original 20-item PAID que
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3861951fa4fef7475f3254b71db53358
https://nottingham-repository.worktribe.com/file/1487854/1/PAID-11
https://nottingham-repository.worktribe.com/file/1487854/1/PAID-11
Autor:
Bradburn MJ; Clinical Trials Research Unit, University of Sheffield, Sheffield, UK. Electronic address: m.bradburn@sheffield.ac.uk., Lee EC; Clinical Trials Research Unit, University of Sheffield, Sheffield, UK., White DA; Clinical Trials Research Unit, University of Sheffield, Sheffield, UK., Hind D; Clinical Trials Research Unit, University of Sheffield, Sheffield, UK., Waugh NR; Warwick Medical School, University of Warwick, UK., Cooke DD; School of Health Sciences, University of Surrey, UK., Hopkins D; Institute of Diabetes, Endocrinology & Obesity, King's Health Partners, London, UK., Mansell P; Department of Diabetes and Endocrinology, Nottingham University Hospitals NHS Trust, UK., Heller SR; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Publikováno v:
Journal of clinical epidemiology [J Clin Epidemiol] 2020 Aug; Vol. 124, pp. 126-138. Date of Electronic Publication: 2020 May 11.
Autor:
Fletcher AM; Drug Safety Evaluation, Bristol-Myers Squibb Company, New Brunswick, NJ, 08903, USA. Electronic address: anthony.fletcher@bms.com., Tellier P; Charles River Laboratories, 22022 Transcanadienne, Quebec, H9X 3R3, Canada., Douville J; Charles River Laboratories, 22022 Transcanadienne, Quebec, H9X 3R3, Canada., Mansell P; Charles River Laboratories, 22022 Transcanadienne, Quebec, H9X 3R3, Canada., Graziano MJ; Drug Safety Evaluation, Bristol-Myers Squibb Company, New Brunswick, NJ, 08903, USA., Mangipudy RS; Drug Safety Evaluation, Bristol-Myers Squibb Company, New Brunswick, NJ, 08903, USA., Brodie TA; Drug Safety Evaluation, Bristol-Myers Squibb Company, New Brunswick, NJ, 08903, USA., Achanzar WE; Drug Safety Evaluation, Bristol-Myers Squibb Company, New Brunswick, NJ, 08903, USA.
Publikováno v:
Toxicology letters [Toxicol Lett] 2019 Dec 15; Vol. 317, pp. 120-129. Date of Electronic Publication: 2019 Sep 30.
Autor:
Khoo EY; School of Biomedical Sciences, University of Nottingham, Nottingham, United Kingdom. ekhoo@doctors.org.uk, Risley J, Zaitoun AM, El-Sheikh M, Paisey RB, Acheson AG, Mansell P
Publikováno v:
The American journal of the medical sciences [Am J Med Sci] 2009 May; Vol. 337 (5), pp. 383-5.